Beautiful Virgin Islands

Monday, Oct 06, 2025

Contraceptive ‘mini pills’ to be offered over the counter in UK

Contraceptive ‘mini pills’ to be offered over the counter in UK

Progesterone pills can be dispensed by pharmacists without prescription from late July, for a charge
Women will be able to buy the contraceptive pill over the counter for the first time in 60 years after a landmark ruling from the UK’s drug regulator.

From the end of July two brands of progesterone-only “mini pills” will be available for as little as under £7.50 a month without a prescription and after a brief consultation with a pharmacist, making them much more accessible to a wider range of women and girls.

The pills contain desogestrel, a synthetic progesterone that inhibits ovulation and prevents fertilisation by thickening the cervical mucus and thinning the uterus lining.

The decision was heralded as “good news for women and families” by June Raine, the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA).

“Pharmacists have the expertise to advise women on whether desogestrel is an appropriate and safe oral contraceptive pill for them to use and to give women the information they need, to make informed choices,” she said.

However, sexual health doctors called on the government to make the pills free in community pharmacies, since they are available free of charge with a doctor’s prescription, and to make a wider range of brands available.

The two pills, Lovima and Hana, are considered safe for most women to take. Combined oestrogen and progesterone pills, which still require a prescription, carry risks to women who are over 35 and smoke that are considered to potentially outweigh the benefits.

According to Maxwellia, which manufactures Lovima, a month’s supply will cost £10. HRA Pharma, which produces Hana, said it would cost £9.95 for one month and £21.95 for three. The contraceptive pill was first introduced on the NHS in 1961 – but was prescribed only to married women for the first six years.

Research by the Guardian based on freedom of information requests showed that almost nine in 10 women who received contraception from the GP or pharmacies in 2017-18 took the pill. The combined pill was marginally more popular, with 1.7 million women opting for that (55%) and 1.4 million choosing the mini pill (45%).

The MHRA’s decision to reclassify the desogestrel products follows a safety review by the Commission on Human Medicines (CHM) and a public consultation taking in views from patients, pharmacists and doctors.

Edward Morris, the president of the Royal College of Obstetricians and Gynaecologists, said he was delighted that some contraceptive pills would be available in local pharmacies after the college’s years of campaigning against “unnecessary barriers” for women and girls.

He said: “Even before the pandemic, too many women and girls were struggling to access basic women’s health services. The consequences of this include an increase in the number of unplanned pregnancies, which can result in poorer outcomes for women and their babies.”

Robbie Turner, the director of pharmacy at the Royal Pharmaceutical Society, said community pharmacies tended to be more conveniently located, and that pharmacists were well equipped to provide women with expert advice on contraception.

Asha Kasliwal, the president of Faculty of Sexual and Reproductive Healthcare, said she fully supported the reclassification of progesterone-only pills as a pharmacy medicine.

She said: “The fragmented sexual and reproductive healthcare system is notoriously difficult for women to navigate, and successive cuts to public health budgets have made it harder for women to get the contraception they need. Reclassification may also reduce unnecessary pressures on GPs, who will not need to see patients for repeat prescriptions.

“However, reclassification of some brands is only the first step, and buying contraception should definitely not be the only solution. We are calling for these pills to be available to everyone for free in community pharmacies, as well as the reclassification of other contraceptives.”
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
×